Anbio Biotechnology (NNNN) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to -$13429.0 billion.
- Anbio Biotechnology's Enterprise Value changed N/A to -$13429.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$13429.0 billion, marking a year-over-year change of. This contributed to the annual value of -$11.8 million for FY2024, which is 2136.89% down from last year.
- Anbio Biotechnology's Enterprise Value amounted to -$13429.0 billion in Q2 2025.
- In the past 5 years, Anbio Biotechnology's Enterprise Value registered a high of -$9.7 million during Q4 2023, and its lowest value of -$13429.0 billion during Q2 2025.
- Over the past 3 years, Anbio Biotechnology's median Enterprise Value value was -$11.8 million (recorded in 2024), while the average stood at -$4476.3 billion.
- Examining YoY changes over the last 5 years, Anbio Biotechnology's Enterprise Value showed a top increase of 2136.89% in 2024 and a maximum decrease of 2136.89% in 2024.
- Anbio Biotechnology's Enterprise Value (Quarter) stood at -$9.7 million in 2023, then fell by 21.37% to -$11.8 million in 2024, then plummeted by 114171106.58% to -$13429.0 billion in 2025.
- Its last three reported values are -$13429.0 billion in Q2 2025, -$11.8 million for Q4 2024, and -$9.7 million during Q4 2023.